Top Authors

• Most frequent coverage on ONXX

• 
  SA Editor Miriam Metzinger (528 followers)

  • Cramer's Mad Money - Oh, I'm a Lumberjack, Plum Creek's Okay (12/4/09) (Sun, Dec 6)
  • Cramer's Mad Money - Hey Big Spenders (11/5/09) (Fri, Nov 6)
  • Cramer's Stop Trading! The Total Data Hog (9/21/09) (Tue, Sep 22)

  More by SA Editor Miriam Metzinger on ONXX »
• 
  SA Editors (179 followers)

  • Chart: Biotech Stocks - Revenue Per Employee (Wed, May 31)
  • Chart: Biotech Stocks - Normalized Net Profit Margins (Tue, May 23)
  • Chart: Biotech Stocks - SG&A Margin (MRQ) (Thu, May 11)

  More by SA Editors on ONXX »
• 
  TickerSense (133 followers)

  • Russell 3000's Best and Worst Stocks, Week and Year to Date (Sat, Apr 14)
  • Russell 3000's Best and Worst Stocks, Week and Year to Date (Sun, Apr 8)
  • Russell 3000's Best and Worst Stocks, Week and Year to Date (Sat, Mar 24)

  More by TickerSense on ONXX »

• Most followed authors on ONXX

• 
  TraderMark (3719 followers)

  • 41 Stocks Returning 10% or More Last Week (Sun, Aug 17)

  More by TraderMark on ONXX »
• 
  Bespoke Investment Group (3496 followers)

  • Last Year's Best Stocks Have Been This Year's Worst (Sun, Mar 2)
  • 2007's Best, Worst Performers Faring Poorly in 2008 (Wed, Jan 16)
  • Best Performing Stocks YTD (Thu, Dec 20)

  More by Bespoke Investment Group on ONXX »
• 
  Don Dion (2762 followers)

  • Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile (Thu, Dec 13)

  More by Don Dion on ONXX »

• Newest authors on ONXX

• 
  Raymond Chung (20 followers)

  • Onyx Pharmaceuticals: Is Nexavar the Next Avastin? (Tue, Sep 22)
  • Onyx Pharmaceuticals: Good Reasons for Raising Capital, Investors Overly Concerned (Thu, Aug 13)

  More by Raymond Chung on ONXX »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on ONXX »
• 
  Prohost Biotech (86 followers)

  • Onyx Pharmaceuticals: Could Acquiring Proteolix Be the Deal of the Year? (Thu, Oct 22)
  • Onyx Pharmaceuticals: Nexavar Promising for Metastatic Breast Cancer (Wed, Sep 23)

  More by Prohost Biotech on ONXX »

• Most commented on ONXX

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on ONXX »
• 
  Michael Steinberg (162 followers)

  • Pharmaceutical Dollar Rationing by Results (Wed, Jul 1)
  • U.K. Limits 'Quality of Life' Meds to £30,000 a Year (Sun, Oct 12)

  More by Michael Steinberg on ONXX »
• 
  Zacks.com (1051 followers)

  • Onyx to Acquire Cancer Drugmaker Proeolix (Tue, Oct 13)
  • Bayer / Onyx Cancer Drug: Possible Additional Indication Looks Promising (Sun, Sep 27)
  • Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships (Tue, Jun 2)

  More by Zacks.com on ONXX »